Answers are grounded in this paper and cite their sources.
Shows enhanced virulence of engineered fungi in insects, indicating a new approach for bioinsecticides.
Entomopathogenic fungi represent promising eco-friendly bioinsecticides, but are hindered by low virulence and host immunity. Here, we engineer a novel immune-evasion mechanism by exploiting the host’s own pathogen recognition system. The insect β-1,3-glucan recognition protein 1 (βGRP1), containing a β-glucan-binding CBM39 domain and a glycoside hydrolase (GH16) domain, was identified as a key immune activator in insects. Silencing GmβGRP1 in Galleria mellonella significantly increased susceptibility to Beauveria bassiana . We engineered B. bassiana to secrete a catalytically inactive GmβGRP1 variant (GH16-deficient GmβGRP1 cbm ) that preemptively binds fungal β-glucans but lacks immune-activating capacity. This engineered strain exhibited significantly accelerated killing across diverse insects and transferred enhanced virulence to Metarhizium robertsii . Mechanistic studies confirmed that GmβGRP1 cbm masks fungal β-glucan epitopes, preventing recognition and downstream immune activation. This “stealth” strategy─hijacking host immunity through preemptive occupation with decoy proteins─provides a paradigm shift toward next-generation bioinsecticides combining efficacy with environmental sustainability.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: